|
WO2020161543A1
|
|
Method of controlling progression of hyperparathyroidism with calcifediol, and compositions for use therein
|
|
US2020262887A1
|
|
Oxyntomodulin peptide analog formulations
|
|
US2020129545A1
|
|
Methods of treatment with mixed metal compound
|
|
AU2019329905A1
|
|
Vitamin D pediatric dosage forms, methods of making and using
|
|
AU2019248829A1
|
|
Use of calcifediol in bariatric surgery patients
|
|
CN108883120A
|
|
Vitamin D treatment method
|
|
US2018085381A1
|
|
Adjunctive Therapy With 25-Hydroxyvitamin D
|
|
EP2427484A1
|
|
Method and composition for measuring the amount of vitamin d derivatives
|
|
EP3659608A1
|
|
Therapy using vitamin d repletion agent and vitamin d hormone replacement agent
|
|
EP1883626A2
|
|
Low-calcemic 16,23-diene 25-oxime analogs of 1alpha,25-dihydroxy vitamin d3
|
